Elicio Therapeutics
ELTX
ELTX
17 hedge funds and large institutions have $2.25M invested in Elicio Therapeutics in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.75K |
| 2 |
BlackRock
New York
|
+$602 |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
+$332 |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$64.7K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$62.9K |
| 3 |
CM
CM Management
Gulf Breeze,
Florida
|
-$51K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4.25K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$4.18K |
